Trials / Unknown
UnknownNCT04579562
Regional COVID Epidemiology in England (RECEDE)
Regional Epidemiology of COVID-19 and Acute Kidney Injury in England
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- University Hospitals of Derby and Burton NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 110 Years
- Healthy volunteers
- Not accepted
Summary
The COVID-19 pandemic has exposed the unwanted variation in outcomes as evidence by Public Health England's report on increased mortality in regions of the country. For example, UHDB, in East Midlands, has reported a high crude mortality as compared to other Trusts in the region.8 There may also have been variation in the incidence of complications of COVID-19 in the form of AKI, which may have influenced mortality. Variation in outcomes may be because of various factors - differing population demographics, underlying health conditions in the population, deprivation, physician preference and knowledge and ethnic diversity. Unwanted variation is care that is not consistent with a patient's preference or related to \[their\] underlying illness. It is important to understand the reason for unwanted variation in outcomes associated with COVID-19 to minimise patient harm and reduce morbidity and mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | This is observational, non-interventional study |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-03-31
- Completion
- 2021-10-31
- First posted
- 2020-10-08
- Last updated
- 2020-10-08
Source: ClinicalTrials.gov record NCT04579562. Inclusion in this directory is not an endorsement.